Innovation
Blue Bees Therapeutics: boosting immune cells to treat cancer
… new €10 million round of financing in April 2023 to finance human clinical trials for its first drug candidate, BB-100, … BB-100 is produced recombinantly using HEK 293 cells, human embryonic kidney cells, which are traditionally used … its biological properties in in vitro models, notably in human cells, and in vivo in animals. In animals, the tumour …Published on: